BDTX's logo.
Ticker Symbol: BDTX

Black Diamond Therapeutics Inc

$7.62 - 02-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001701541

Company Profile

black diamond therapeutics, inc., a precision oncology medicine company, discovers and develops small molecule, tumor-agnostic therapies. its lead product candidate is bdtx-189, an inhibitor of non-canonical and oncogenic mutations of erbb kinases epidermal growth factor receptor (egfr) and tyrosine-protein kinase. the company is also developing allosteric-egfr mutation inhibitors; and various early stage pipeline programs targeting allosteric mutations in kinases related to cancer and/or rare genetic diseases. the company was formerly known as aset therapeutics, inc. and changed its name to black diamond therapeutics, inc. in january 2018. black diamond therapeutics, inc. was founded in 2014 and is headquartered in cambridge, massachusetts.

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
CEO: N/A
Tags:
  • Health Technology
  • Biotechnology

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $2.10
Change: -$0.02 ( -1.18%)
Days Range: $2.02 - $2.16
Beta: 2.33
52wk. High: $6.85
52wk. Low: $1.22
Ytd. Change 15.49%
50 Day Moving Average: $3.00
200 Day Moving Average: $2.84
Shares Outstanding: 51575323

Valuation

Market Cap: 10.8B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A